This content is machine translated Immunotherapies CAR-T for pemphigus vulgaris as a future therapeutic option? In recent years, great progress has been made in the study of autologous immunocellular therapies. The development of a target-specific chimeric antigen receptor (CAR) against pathogenetic autoreactive B-cell pemphigus vulgaris…
